Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy

Cardiovascular Research

Volumn 63, Issue 3, 2004, Pages 403-413

  Proud, Christopher G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Hypertrophy; MAP kinase; mRNA translation; mTOR; PI3 kinase; Protein synthesis; Ras

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; INITIATION FACTOR 4E; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAS PROTEIN; S6 KINASE; TARGET OF RAPAMYCIN KINASE;

BIOGENESIS; CELL GROWTH; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART HYPERTROPHY; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; RIBOSOME; RNA TRANSLATION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CARDIOMEGALY; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; PROTEIN BIOSYNTHESIS; RAS PROTEINS; SIGNAL TRANSDUCTION; SIROLIMUS;

EID: 3242793344     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.02.003     Document Type: Review

References (110)

1. Akhter S.A., Luttrell L.M., Rockman H.A., Iaccarino G., Lefkowitz R.J., Koch W.J. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science. 280:1998;574-577
2. Antos C.L., McKinsey T.A., Frey N., et al. Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. U. S. A. 99:2002;907-912
3. Avruch J., Belham C., Weng Q., Hara K., Yonezawa K. The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog. Mol. Subcell. Biol. 26:2001;115-154
4. Bogoyevitch M.A., Glennon P.E., Andersson M.R., et al. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signalling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signalling pathways leading to myocyte hypertrophy. J. Biol. Chem. 269:1994;1110-1119
5. Bogoyevitch M.A., Glennon P.E., Sugden P.H. Endothelin-1, TPA and phenylephrine stimulate mitogen-activated protein kinase in ventricular cardiomyocytes. FEBS Lett. 317:1993;271-275
6. Bogoyevitch M.A., Marshall C.J., Sugden P.H. Hypertrophic agonists stimulate the activities of the protein kinases A-Raf and C-Raf in cultured ventricular myocytes. J. Biol. Chem. 270:1995;26303-26310
7. M.O. Boluyt, J.S. Zheng, A. Younes, et al., Rapamycin inhibits α1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase. Circ. Res. 81 176-186.
8. Browne G.J., Proud C.G. Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 269:2002;5360-5368
9. Bueno O.F., De Windt L.J., Tymitz K.M., et al. M.E. TheK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19:2000;6341-6350
10. Bueno O.F., Molkentin J.D. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 91:2002;776-781
11. Camps M., Nichols A., Gillieron C., et al. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science. 280:1998;1262-1265
12. Choukroun G., Hajjar R., Kyriakis J.M., Bonventre J.V., Rosenzweig A., Force T. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. J. Clin. Invest. 102:1998;1311-1320
13. Clerk A., Bogoyevitch M.A., Andersson M.R., Sugden P.H. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J. Biol. Chem. 269:1994;32848-32857
14. Clerk A., Sugden P.H. Activation of protein kinase cascades in the heart by hypertrophic G-protein coupled receptor agonists. Am. J. Cardiol. 83:1999;64H-69H
15. Condorelli G., Drusco A., Stassi G., et al. Akt induces myocardial contractility and cell size in vivo in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 99:2002;12333-12338
16. Cuenda A., Alessi D.R. Use of kinase inhibitors to dissect signaling pathways. Methods Mol. Biol. 99:2000;161-175
17. Delaughter M.C., Taffet G.E., Fiorotto M.L., Entman M.L., Schwartz R.J. Local insulin-like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice. FASEB J. 13:1999;1923-1929
18. Everett A.D., Stoops T.D., Nairn A.C., Brautigan D. Angiotensin II regulates phosphorylation of translation elongation factor-2 in cardiac myocytes. Am. J. Physiol. 281:2001;H161-H167
19. Frey N., Olson E.N. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 65:2003;45-79
20. Fuller S.J., Gillespie-Brown J., Sugden P.H. Oncogenic src, raf, and ras stimulate a hypertrophic pattern of gene expression and increase cell size in neonatal rat ventricular myocytes. J. Biol. Chem. 273:1998;18146-18152
21. Gao X., Pan D. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev. 15:2001;1383-1392
22. Gillespie-Brown J., Fuller S.J., Bogoyevitch M.A., Cowley S., Sugden P.H. The mitogen-activated protein kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular myocytes. J. Biol. Chem. 270:1995;28092-28096
23. Gingras A.-C., Raught B., Sonenberg N. Control of translation by the target of rapamycin proteins. Prog. Mol. Subcell. Biol. 27:2001;143-174
24. Hannan K.M., Brandenburger Y., Jenkins A., et al. mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol. Cell Biol. 23:2003;8862-8877
25. Hannan R.D., Jenkins A., Jenkins A.K., Brandenburger Y. Cardiac hypertrophy: a matter of translation. Clin. Exp. Pharmacol. Physiol. 30:2003;517-527
26. Haq S., Choukroun G., Kang Z.B., et al. Glycogen synthase kinase-3β is a negative regulator of cardiomyocyte hypertrophy. J. Cell Biol. 151:2000;117-130
27. Herbert T.P., Kilhams G.R., Batty I.H., Proud C.G. Distinct signalling pathways mediate insulin and phorbol ester-stimulated eIF4F assembly and protein synthesis in HEK 293 cells. J. Biol. Chem. 275:2000;11249-11256
28. Herbert T.P., Tee A.R., Proud C.G. The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites. J. Biol. Chem. 277:2002;11591-11596
29. Hinnebusch A.G. Mechanism and regulation of methionyl-tRNA binding to ribosomes. Sonenberg N., Hershey J.W., Mathews M.B. Translational Control of Gene Expression. 2000;185-243 Cold Spring Harbor Laboratory PressM, Cold Spring Harbor, New York, USA
30. Hunter J.J., Tanaka N., Rockman H.A., Ross J. Jr., Chien K.R. Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J. Biol. Chem. 270:1995;23173-23178
31. Inoki K., Li Y., Xu T., Guan K.L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17:2003;1829-1834
32. Ishida M., Ishida T., Nakashima H., Miho N., Miyagawa K., Chayama K., et al. Mnk1 is required for angiotensin II-induced protein synthesis in vascular smooth muscle cells. Circ. Res. 93:2003;1218-1224
33. Ito N., Rubin G.M. Gigas, a Drosophila homolog of tuberous sclerosis gene product-2, regulates the cell cycle. Cell. 96:1999;529-539
34. Jaeschke A., Hartkamp J., Saitoh M., et al. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J. Cell Biol. 159:2002;217-224
35. S6k. EMBO J. 16:1997;3693-3704
36. Kawai M., Kawashima S., Sakoda T., et al. Ral GDP dissociation stimulator and Ral GTPase are involved in myocardial hypertrophy. Hypertension. 41:2003;956-962
37. Keyse S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12:2000;186-192
38. Kodama Y., Umemura Y., Nagasawa S., et al. Exercise and mechanical loading increase periosteal bone formation and whole bone strength in C57BL/6J mice but not in C3H/Hej mice. Calcif. Tissue Int. 66:2000;298-306
39. Kovacic B., Ilic D., Damsky C.H., Gardner D.G. c-Src activation plays a role in endothelin-dependent hypertrophy of the cardiac myocyte. J. Biol. Chem. 273:1998;35185-35193
40. Koziris L.P., Hickson R.C., Chatterton R.T. Jr., et al. Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J. Appl. Physiol. 86:1999;1436-1442
41. Leevers S.J. Growth control: invertebrate insulin surprises! Curr. Biol. 11:2001;R209-R212
42. Leevers S.J., Weinkove D., MacDougall L.K., Hafen E., Waterfield M.D. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15:1996;6584-6594
43. Manning B.D., Cantley L.C. Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 28:2003;573-576
44. Manning B.D., Tee A.R., Logsdon M.N., Blenis J., Cantley L.C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell. 10:2002;151-162
45. Martin K.A., Schalm S.S., Romanelli A., Keon K.L., Blenis J. Ribosomal S6 kinase 2 inhibition by a potent C-terminal repressor domain is relieved by mitogen-activated protein-extracellular signal-regulated kinase kinase-regulated phosphorylation. J. Biol. Chem. 276:2001;7892-7898
46. Marygold S.J., Leevers S.J. Growth signaling: TSC takes its place. Curr. Biol. 12:2002;R785-R787
47. Matsui T., Li L., Wu J.C., et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J. Biol. Chem. 277:2002;22901-22986
48. McLeod L.E., Wang L., Proud C.G. β-Adrenergic agonists increase phosphorylation of elongation factor 2 in cardiomyocytes without eliciting calcium-independent eEF2 kinase activity. FEBS Lett. 489:2001;225-228
49. McManus E.J., Alessi D.R. TSC1-TSC2: a complex tale of PKB-mediated S6K regulation. Nat. Cell Biol. 4:2002;E214-E216
50. McMullen J.R., Shioi T., Zhang L., et al. Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 100:2003;12355-12360
51. Meyuhas O., Hornstein E. Translational control of TOP mRNAs. Sonenberg N., Hershey J.W., Mathews M.B. Translational Control of Gene Expression. 2000;671-693 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, USA
52. Minich W.B., Balasta M.L., Goss D.J., Rhoads R.E. Chromatographic resolution of in vivo phosphorylated and nonphosphorylated eukaryotic translation initiation factor eIF-4E: increased cap affinity of the phosphorylated form. Proc. Natl. Acad. Sci. U. S. A. 91:1994;7668-7672
53. Molkentin J.D., Dorn G.W. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu. Rev. Physiol. 63:2001;391-426
54. Montagne J., Stewart M.J., Stocker H., Hafen E., Kozma S.C., Thomas G. Drosophila S6 kinase: a regulator of cell size. Science. 285:1999;2126-2129
55. Nichols A., Camps M., Gillieron C., et al. Substrate recognition domains within extracellular signal-regulated kinase mediate binding and catalytic activation of mitogen-activated protein kinase phosphatase-3. J. Biol. Chem. 275:2000;24613-24621
56. Onda H., Lueck A., Marks P.W., Warren H.B., Kwiatkowski D.J. Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J. Clin. Invest. 104:1999;687-695
57. Post G.R., Goldstein D., Thuerauf D.J., Glembotski C.C., Brown J.H. Dissociation of p44 and p42 mitogen-activated protein kinase from receptor-induced hypertrophy in neonatal ventricular myocytes. J. Biol. Chem. 271:1996;8452-8457
58. Potter C.J., Huang H., Xu T. Drosophilasc Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell. 105:2001;357-368
59. Proud CG. Control of the elongation phase of protein synthesis. In: Translational Control of Gene Expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New Tork, USA.
60. Proud C.G. Regulation of mammalian translation factors by nutrients. Eur. J. Biochem. 269:2002;5338-5349
61. Ramirez M.T., Sah V.P., Zhao X.L., Hunter J.J., Chien K.R., Brown J.H. The MEKK-JNK pathway is stimulated by alpha1-adrenergic receptor and Ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J. Biol. Chem. 272:1997;14057-14061
62. Rapacciuolo A., Esposito G., Caron K., Mao L., Thomas S.A., Rockman H.A. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy. J. Am. Coll. Cardiol. 38:2001;876-882
63. Raught B., Gingras A.-C., Sonenberg N. Regulation of ribosome recruitment in eukaryotes. Sonenberg N., Hershey J.W., Mathews M.B. Translational Control of Gene Expression. 2000;245-293 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, USA
64. Redaelli G., Malhotra A., Li B., et al. Effects of constitutive overexpression of insulin-like growth factor-1 on the mechanical characteristics and molecular properties of ventricular myocytes. Circ. Res. 82:1998;594-603
65. Reiss K., Cheng W., Ferber A., et al. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 93:1996;8630-8635
66. Rockman H.A., Koch W.J., Lefkowitz R.J. Seven-transmembrane-spanning receptors and heart function. Nature. 415:2002;206-212
67. Rohde J., Heitman J., Cardenas M.E. The TOR kinases link nutrient sensing to cell growth. J. Biol. Chem. 276:2001;9583-9586
68. Ryazanov A.G., Ward M.D., Mendola C.E., et al. Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4884-4889
69. Sadoshima J., Izumo S. Rapamycin selectively inhibits angiotensin II induced increase in protein synthesis in cardiac myocytes in vitro. Circ. Res. 77:1995;1040-1052
70. Sadoshima J., Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 12:1993;1681-1692
71. Scheid M.P., Woodgett J.R. PKB/AKT: functional insights from genetic models. Nat. Rev., Mol. Cell Biol. 2:2001;760-768
72. Scheid M.P., Woodgett J.R. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett. 546:2003;108-112
73. Scheper G.C., Morrice N.A., Kleijn M., Proud C.G. The MAP kinase signal-integrating kinase Mnk2 is an eIF4E kinase with high basal activity in mammalian cells. Mol. Cell. Biol. 21:2001;743-754
74. Scheper G.C., Proud C.G. Does phosphorylation of the cap-binding protein eIF4E play a role in translation initiation? Eur. J. Biochem. 269:2002;5350-5359
75. Scheper G.C., van Kollenburg B., Hu J., Luo Y., Goss D.J., Proud C.G. Phosphorylation of eukaryotic initiation factor 4E markedly reduces its affinity for capped mRNA. J. Biol. Chem. 277:2002;3303-3309
76. Schwartzbauer G., Robbins J. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J. Biol. Chem. 276:2001;35786-35793
77. Shima H., Pende M., Chen Y., Fumagalli S., Thomas G., Kozma S.C. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17:1998;6649-6659
78. Shioi T., Kang P.M., Douglas P.S., et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19:2000;2537-2548
79. Shioi T., McMullen J.R., Kang P.M., et al. Akt/protein kinase B promotes organ growth in transgenic mice. Mol. Cell. Biol. 22:2002;2799-2809
80. Shioi T., McMullen J.R., Tarnavski O., et al. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation. 107:2003;1664-1670
81. Silberbach M., Gorenc T., Hershberger R.E., Stork P.J., Steyger P.S., Roberts C.T. Jr. Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J. Biol. Chem. 274:1999;24858-24864
82. Stefanovsky V.Y., Pelletier G., Hannan R., Gagnon-Kugler T., Rothblum L.I., Moss T. An immediate response of ribosomal transcription to growth factor stimulation in mammals is mediated by ERK phosphorylation of UBF. Mol. Cell. 8:2001;1063-1073
83. Sugden P.H. Signaling in myocardial hypertrophy: life after calcineurin? Circ. Res. 84:1999;633-646
84. Sugden P.H., Clerk A. Activation of the small GTP-binding protein Ras in the heart by hypertrophic agonists. Trends Cardiovasc. Med. 10:2000;1-8
85. Sutherland C., Leighton I.A., Cohen P. Inactivation of glycogen synthase kinase-3β by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem. J. 296:1993;15-19
86. Takeishi Y., Huang Q., Abe J., et al. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch. J. Mol. Cell. Cardiol. 33:2001;1637-1648
87. Tang H., Hornstein E., Stolovich M., et al. Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signalling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol. Cell. Biol. 21:2001;8671-8683
88. Tee A.R., Anjum R., Blenis J. Inactivation of the tuberous sclerosis complex-1 and -2 gene products occurs by phosphoinositide 3-kinase/Akt-dependent and -independent phosphorylation of tuberin. J. Biol. Chem. 278:2003;37288-37296
89. Tee A.R., Fingar D.C., Manning B.D., Kwiatkowski D.J., Cantley L.C., Blenis J. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl. Acad. Sci. U. S. A. 99:2002;13571-13576
90. Thomas G., Hall M.N. TOR signalling and the control of cell growth. Curr. Opin. Cell. Biol. 9:1998;782-787
91. Thorburn A. Ras activity is required for phenylephrine-induced activation of mitogen-activated protein kinase in cardiac muscle cells. Biochem. Biophys. Res. Commun. 205:1994;1417-1422
92. Thorburn A., Thorburn J., Chen S.-Y., et al. HRas dependent pathways can activate morphological and genetic markers of cardiac cell hypertrophy. J. Biol. Chem. 268:1993;2244-2249
93. Thorburn J., Carlson M., Mansour S.J., Chien K.R., Ahn N.G., Thorburn A. Inhibition of a signalling pathway in cardiac muscle cells by active mitogen activated protein kinase kinase. Mol. Biol. Cell. 6:1995;1479-1490
94. Thorburn J., Frost J.A., Thorburn A. Mitogen-activated protein kinases mediate changes in gene expression but not cytoskeletal organisation associated with cardiac muscle hypertrophy. J. Cell. Biol. 126:1994;1565-1572
95. Thorburn J., McMahon M., Thorburn A. Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy. J. Biol. Chem. 269:1994;30580-30586
96. Tu V.C., Bahl J.J., Chen Q.M. Signals of oxidant-induced cardiomyocyte hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase. J. Pharmacol. Exp. Ther. 300:2002;1101-1110
97. Vanhaesebroeck B., Alessi D.R. The P13K-PDK1 connection: more than just a road to PKB. Biochem. J. 346:2000;561-576
98. Wang L., Gout I., Proud C.G. Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways. MEK-dependent activation of S6K2 in cardiomyocytes. J. Biol. Chem. 276:2001;32670-32677
99. Wang L., Proud C.G. Ras/Erk signalling is required for regulation of translation factors linked to mTOR and protein synthesis by hypertrophic agents in cardiomyocytes. Circ. Res. 91:2002;821-829
100. Wang L., Proud C.G. Regulation of the phosphorylation of elongation factor 2 by MEK-dependent signalling in adult rat cardiomyocytes. FEBS Lett. 531:2002;285-289
101. Wang L., Wang X., Proud C.G. Activation of mRNA translation by insulin in rat cardiomyocytes involves multiple rapamycin-sensitive steps. Am. J. Physiol. 278:2000;H1056-H1068
102. Wang X., Janmaat M., Beugnet A., Paulin F.E.M., Proud C.G. Evidence that the dephosphorylation of Ser535 in the epsilon-subunit of eukaryotic initiation factor 2B is insufficient for the activation of eIF2B by insulin. Biochem. J. 367:2002;475-481
103. RSK1 and p70 S6 kinase. EMBO J. 20:2001;4370-4379
104. Welsh G.I., Miller C.M., Loughlin A.J., Price N.T., Proud C.G. Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett. 421:1998;125-130
105. Wettschureck N., Rutten H., Zywietz A., Gehring D., Wilkie T.M., Chen J., et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. Nat. Med. 7:2001;1236-1240
106. Xiao L., Pimental D.R., Amin J.K., Singh K.S.D.B., Sawyer D.B., Colucci W.S. MEK1/2-ERK1/2 mediates α1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J. Mol. Cell. Cardiol. 33:2001;779-787
107. Yeh J.K., Aloia J.F., Chen M., Ling N., Koo H.C., Millard W.J. Effect of growth hormone administration and treadmill exercise on serum and skeletal IGF-I in rats. Am. J. Physiol. 266:1994;E129-E135
108. Yue T.-L., Gu J.-L., Wang C., et al. Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J. Biol. Chem. 275:2000;37895-37901
109. Zechner D., Thuerauf D.J., Hanford D.S., McDonough P.M., Glembotski C.C. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J. Cell. Biol. 139:1997;115-127
110. Zhang S., Weinheimer C., Courtois M., et al. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J. Clin. Invest. 111:2003;833-841